top of page

Focused on Cures
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients
“I am optimistic that Excision’s technology and approach using CRISPR could potentially cure infectious diseases and bring much needed therapies to those in need around the world.”
Jennifer Doudna, Ph.D., CRISPR Co-inventor
UC Berkeley, 2020
OUR
Partners











499 Jackson Street
San Francisco, CA 94111
USA
bottom of page